Back
Natural Grocers by Vitamin Cottage, Inc. 10K Form
Sell
29
NGVC
Natural Grocers by Vitamin Cottage, Inc.
Last Price:
$25.11
Seasonality Move:
3.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NGVC News And Ratings
See the #1 stock for the next 7 days that we like better than NGVC
NGVC Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3B |
|---|---|
| Cash Flow: | $42M |
| Price / Cash Flow: | 10 |
| Annual Sales: | $9.25 |
| Price / Book: | 2.71 |
Profitability
| EPS (TTM): | 1.99970 |
|---|---|
| Net Income (TTM): | $46.4M |
| Gross Margin: | $397.9M |
| Return on Equity: | 24.09% |
| Return on Assets: | 6.86% |
Natural Grocers by Vitamin Cottage, Inc. Earnings Forecast
Key Natural Grocers by Vitamin Cottage, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for NGVC is 29.90%.
-
The Selling, General & Administrative Expenses for NGVC have been equal to 3.33% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 6.60% of Operating Income.
-
The Net Earning history of NGVC is 3.49% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 12 years.
Natural Grocers by Vitamin Cottage, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Consumer Staples Distribution & Retail |
| Sector: | Consumer Staples |
| Current Symbol: | NGVC |
| CUSIP: | 63888U |
| Website: | naturalgrocers.com |
Debt
| Debt-to-Equity Ratio: | 1.56 |
|---|---|
| Current Ratio: | 1.06 |
| Quick Ratio: | 0.18 |
Price-to-Earnings
| Trailing P/E Ratio: | 12.54 |
|---|---|
| Forward P/E Ratio: | 11.05 |
NGVC Technical Analysis vs Fundamental Analysis
Sell
29
Natural Grocers by Vitamin Cottage, Inc. (NGVC)
is a Sell
Is Natural Grocers by Vitamin Cottage, Inc. a Buy or a Sell?
-
Natural Grocers by Vitamin Cottage, Inc. stock is rated a SellThe current Natural Grocers by Vitamin Cottage, Inc. [NGVC] share price is $25.08. The Score for NGVC is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.